Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses.
about
Oncolytic viruses as therapeutic cancer vaccinesImproved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2Intelligent design: combination therapy with oncolytic virusesER chaperones in mammalian development and human diseasesImmunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse modelAdministration of cyclophosphamide changes the immune profile of tumor-bearing miceTRAIL in cancer therapy: present and future challenges.Selectivity of oncolytic viral replication prevents antiviral immune response and toxicity, but does not improve antitumoral immunity.Evaluation of adenovirus vectors containing serotype 35 fibers for vaccinationGM-CSF gene-modifed cancer cell immunotherapies: of mice and men.Antitumor activity of mixed heat shock protein/peptide vaccine and cyclophosphamide plus interleukin-12 in mice sarcoma.Gene therapy progress and prospects cancer: oncolytic viruses.Adenovirus-mediated intratumoral expression of immunostimulatory proteins in combination with systemic Treg inactivation induces tumor-destructive immune responses in mouse modelsImmunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model.Spontaneous tumor rejection by cbl-b-deficient CD8+ T cellsDC targeting DNA vaccines induce protective and therapeutic antitumor immunity in mice.Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61Oncolytic virotherapy as a personalized cancer vaccine.Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression.Armed replicating adenoviruses for cancer virotherapy.Pharmacologic and chemical adjuvants in tumor virotherapy.The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon.Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma modelNew perspectives in cancer virotherapy: bringing the immune system into play.Combining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach.Conditionally replicating adenoviruses carrying mda-7/IL-24 for cancer therapy.Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers.The interplay between the immune system and chemotherapy: emerging methods for optimizing therapy.Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice.Adenovirus-based virotherapy enabled by cellular YB-1 expression in vitro and in vivo.Synergistic antitumor effects of transarterial viroembolization for multifocal hepatocellular carcinoma in rats.Use of biological therapy to enhance both virotherapy and adoptive T-cell therapy for cancer.Oncolytic viruses from the perspective of the immune system.E1A-expressing adenoviral E3B mutants act synergistically with chemotherapeutics in immunocompetent tumor models.Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting.Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus.Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics.Vesicular stomatitis virus-induced immune suppressor cells generate antagonism between intratumoral oncolytic virus and cyclophosphamideImmunological Mechanisms of Low and Ultra-Low Dose Cancer Chemotherapy.Adenovirus Lacking E1b Efficiently Induces Cytopathic Effect in HPV-16-Positive Murine Cancer Cells via Virus Replication and Apoptosis.
P2860
Q21245758-5CB643DC-05E5-4CEF-BD6B-8D4FFF4C4E5FQ24612603-3E1A16CE-00A6-4091-B4A6-FE1C1B7FB243Q24628227-D93AE22E-6A1C-4D23-BC0A-FFEEE1A99A29Q28300625-65F1267F-8E67-4403-B69D-81A30C0E830CQ30940594-0FE2C39E-5BEA-41ED-8A1B-D51831586FA9Q33611809-804E9FA4-2959-4729-9F2D-B1D656A08754Q34291312-799E43CB-59CD-4314-8FD8-5205367C5322Q34343742-EEB78013-34B0-49D6-8ED1-55753A040929Q34507185-762BCF24-B97A-42E9-B08F-36C6B7C56413Q34591128-61C2A6C6-CFA4-492F-B7FA-61A6553FAF78Q34668901-FD355FF5-B473-4083-BE9B-A5314EA1D7F6Q34770611-8404C461-0060-49AA-8054-929FA3E0E209Q34988018-635771CE-E81B-4B8A-B002-75CD82534599Q36221386-FFAE6768-6CB9-47C4-B831-1D14BC462E2FQ36229277-634646CA-3B70-4E50-AF86-F37025878B63Q36411564-16CCB42C-E675-4639-9BC5-B135B2445BA1Q37138130-D4764688-E2B9-4271-96BC-2203899BD9B7Q37171980-6622CC83-9A9D-4CA7-915C-19C5992A7726Q37270469-02636560-4873-4A3A-8085-EB462D306695Q37386616-6A3363FB-185B-4F82-AEF3-DB05283E076DQ37492540-B2026F93-D4EE-4E99-8B3C-B3C47AA4C732Q37561072-8E4190E7-1D9D-45F2-AF47-4DBB2CA3B090Q37727843-DA136388-748F-474D-A5BB-CD18A73B86C1Q37773253-37F459F8-D2AD-4E50-A5F7-A0D2B4D5687DQ37867584-BCD78716-BEC7-4947-8312-A6353472EC5BQ37945288-0E28EBCB-396B-4C7E-A456-6F75BB0D75B3Q38073096-1AFCEDB8-F8F3-46CD-A1D3-6A2DDCE7D306Q38168953-4046BB78-441C-4570-A173-5732B662A26EQ39298850-5F5D8CD8-E4D6-4D2A-B957-A8D944EECD31Q39861470-E2C98BAB-3F3E-49FD-9537-52712054D10BQ39917875-B1A91F59-F4F2-4B0F-8699-48D5E875D2F3Q39933904-D9198DC2-378D-4C7C-B98F-D1463E563CC8Q39974038-9D1EA941-CC5F-4284-9CE3-16E91DA9EFE6Q40045957-237FAC32-F561-470C-9184-6345A300683DQ40250421-C8931134-18CA-4E81-AC51-9EC2AA6F9014Q42063211-E4EE43C4-EAE3-4DE0-8AE1-A6D7A8D0FA8AQ42080758-5804B17C-FE62-4C6E-A02C-7F7D0D53787FQ42157100-BE9A1DEF-ECD1-4176-B39D-FD555DCC5A7AQ42701148-CF94223E-0D1D-4C25-9258-5A9D123C0E1AQ47547236-BDFCBF7F-6F6B-49BF-B8F4-6425F205F7B1
P2860
Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Effect of adenovirus-mediated ...... on antitumor immune responses.
@en
type
label
Effect of adenovirus-mediated ...... on antitumor immune responses.
@en
prefLabel
Effect of adenovirus-mediated ...... on antitumor immune responses.
@en
P2093
P2860
P1433
P1476
Effect of adenovirus-mediated ...... on antitumor immune responses.
@en
P2093
André Lieber
Ingegerd Hellström
Karl Erik Hellström
Nelson C Di Paolo
Sebastian Tuve
Shaoheng Ni
P2860
P304
P356
10.1158/0008-5472.CAN-05-2388
P407
P577
2006-01-01T00:00:00Z